SCHEMBL905101

SCHEMBL905101

Cc1oc(=O)n(C)c1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1400093 0.76 LIPE (0.31) —
SCHEMBL15918966 0.70 — —
SCHEMBL1400145 0.70 KDM4E (0.34) —
SCHEMBL12019536 0.67 ALDH2 (0.44) —
SCHEMBL10044026 0.67 ATAD2 (0.36) —
SCHEMBL2908849 0.65 — —
SCHEMBL1399975 0.62 CA1 (0.39) —
SCHEMBL278526 0.60 — —
SCHEMBL10049703 0.59 KDM4E (0.32) —
SCHEMBL13865236 0.59 CASP3 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023009612-A1 ACORAMIDIS (3-(3-(3,5-DIMETHYL-1H-PYRAZOL-4-YL)PROPOXY)-4-FLUOROBENZOIC ACID) DERIVATIVES FOR STABILIZING TRANSTHYRETIN (TTS) AND INHIBITING TTS MISFOLDING FOR THE TREATMENT OF E.G. PERIPHERAL TTR AMYLOIDOSIS PROTEGO BIOPHARMA, INC. (US) 2023-02-02 — — WO disclosed
WO-2018031680-A1 NOVEL COMPOUNDS, USES AND METHODS FOR THEIR PREPARATION FRONTHERA U.S. PHARMACEUTICALS LLC (US) 2018-02-15 — — WO disclosed
US-9382481-B2 Polarizing film, display device and production process thereof FUJIFILM CORPORATION (JP) 2016-07-05 — — US disclosed
US-8975235-B2 Lysophosphatidic acid receptor antagonists INTERMUNE, INC. (US) 2015-03-10 — — US disclosed
WO-2014164533-A1 METHODS OF STEREOSELECTIVE SYNTHESIS OF SUBSTITUTED NUCLEOSIDE ANALOGS VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-10-09 — — WO disclosed
US-20140213538-A1 LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS INTERMUNE, INC. 2014-07-31 — — US disclosed
WO-2014113485-A1 LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS INTERMUNE, INC. (US) 2014-07-24 — — WO disclosed
US-20140200215-A1 LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS INTERMUNE, INC. 2014-07-17 — — US disclosed
US-20130120676-A1 STEREO IMAGE PRINT AND METHOD OF PRODUCING THE SAME FUJIFILM CORPORATION (JP) 2013-05-16 — — US disclosed
US-20130072449-A1 LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS INTERMUNE, INC. (US) 2013-03-21 — — US disclosed
US-20130070899-A1 POLARIZING FILM, DISPLAY DEVICE AND PRODUCTION PROCESS THEREOF FUJIFILM CORPORATION (JP) 2013-03-21 — — US disclosed
US-20120270071-A1 CHROMENE COMPOUND TOKUYAMA CORPORATION (JP) 2012-10-25 — — US disclosed
US-20120270071-A1 CHROMENE COMPOUND TOKUYAMA CORPORATION (JP) 2012-10-25 — — US disclosed
WO-2012043505-A1 NOVEL PIPERIDINE DERIVATIVE AND PHARMACEUTICAL CONTAINING SAME 興和株式会社 (JP) 2012-04-05 — — WO disclosed
US-7998950-B2 Antiviral compounds GILEAD SCIENCES, INC. (US) 2011-08-16 — — US disclosed
US-7998950-B2 Antiviral compounds GILEAD SCIENCES, INC. (US) 2011-08-16 — — US disclosed
US-20100022508-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2010-01-28 — — US disclosed
US-20100022508-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2010-01-28 — — US disclosed
Send feedback